CY1108013T1 - Dna εμβολια για τους ιππους που περιεχουν ανοσοενισχυτικους παραγοντες με πολυμερη του ακρυλικου ή μεθακρυλικου οξεος ή του εμα(r) - Google Patents

Dna εμβολια για τους ιππους που περιεχουν ανοσοενισχυτικους παραγοντες με πολυμερη του ακρυλικου ή μεθακρυλικου οξεος ή του εμα(r)

Info

Publication number
CY1108013T1
CY1108013T1 CY20071100615T CY071100615T CY1108013T1 CY 1108013 T1 CY1108013 T1 CY 1108013T1 CY 20071100615 T CY20071100615 T CY 20071100615T CY 071100615 T CY071100615 T CY 071100615T CY 1108013 T1 CY1108013 T1 CY 1108013T1
Authority
CY
Cyprus
Prior art keywords
ema
methacrylic acid
immunosuppressive agents
dna vaccines
polymeric acrylic
Prior art date
Application number
CY20071100615T
Other languages
English (en)
Inventor
Jean-Christophe Francis Audonnet
Jules Maarten Minke
Original Assignee
Merial
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9525029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108013(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial filed Critical Merial
Publication of CY1108013T1 publication Critical patent/CY1108013T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

To DNA εμβόλιο περιέχει ένα γυμνό DNA που ενσωματώνει και εκφράζει in vivo μια νουκλεοτιδική αλληλουχία που κωδικοποιεί ένα αντιγονικό πολυπεπτίδιο, κατά προτίμηση ένα γονίδιο ενός παθογόνου παράγοντα, και τουλάχιστον μια ανοσοενισχυτική ένωση που επιλέγεται μεταξύ των ακρυλικών ή μεθακρυλικών πολυμερών και των συμπολυμερών του μηλεϊνικού ανυδρίτη και του παραγώγου του αλκενυλίου. Η ανοσοενισχυτική ένωση είναι κατά προτίμηση ένα καρβομερές ή ένα ΕΜΑ®.
CY20071100615T 1998-04-03 2007-05-09 Dna εμβολια για τους ιππους που περιεχουν ανοσοενισχυτικους παραγοντες με πολυμερη του ακρυλικου ή μεθακρυλικου οξεος ή του εμα(r) CY1108013T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804409A FR2776928B1 (fr) 1998-04-03 1998-04-03 Vaccins adn adjuves
EP99909069A EP1066055B1 (fr) 1998-04-03 1999-03-22 Vaccins à ADN adjuvés avec des polymères d'acide acrylique ou méthacrylique ou d' EMA (R) pour les chevaux

Publications (1)

Publication Number Publication Date
CY1108013T1 true CY1108013T1 (el) 2013-09-04

Family

ID=9525029

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100615T CY1108013T1 (el) 1998-04-03 2007-05-09 Dna εμβολια για τους ιππους που περιεχουν ανοσοενισχυτικους παραγοντες με πολυμερη του ακρυλικου ή μεθακρυλικου οξεος ή του εμα(r)

Country Status (17)

Country Link
US (1) US7163926B1 (el)
EP (1) EP1066055B1 (el)
JP (1) JP2002510651A (el)
AR (1) AR037062A1 (el)
AT (1) ATE353670T1 (el)
AU (1) AU744964B2 (el)
BR (1) BR9909342A (el)
CA (1) CA2327389C (el)
CY (1) CY1108013T1 (el)
DE (1) DE69935136T2 (el)
DK (1) DK1066055T3 (el)
ES (1) ES2283105T3 (el)
FR (1) FR2776928B1 (el)
PL (1) PL194348B1 (el)
PT (1) PT1066055E (el)
WO (1) WO1999051269A1 (el)
ZA (1) ZA992478B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804026B1 (fr) * 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
US6551598B2 (en) 2000-01-21 2003-04-22 Merial Vaccination against canine herpesvirosis and vaccines therefor
CA2470322A1 (en) * 2001-12-14 2003-06-26 Genetronics, Inc. Methods for particle-assisted polynucleotide immunization using a pulsed electric field
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
UA100370C2 (uk) 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
CL2008001806A1 (es) 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
GB0805356D0 (en) * 2008-03-25 2008-04-30 Isis Innovation Vaccine adjuvant composition
MX2010012069A (es) 2008-05-08 2010-12-14 Merial Ltd Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena.
EP2358742B1 (en) * 2008-10-24 2018-02-28 Merial, Inc. Vaccine against african horse sickness virus
CN103957932B (zh) 2011-07-20 2017-06-23 梅里亚有限公司 包含最优化的猫白血病病毒包膜基因的重组猫白血病病毒疫苗
WO2013106558A1 (en) 2012-01-10 2013-07-18 Merial Limited Lipid based adjuvants for dna - plasmid vaccines
WO2013142371A1 (en) 2012-03-20 2013-09-26 Merial Limited Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
MX2015002701A (es) 2012-08-30 2015-12-01 Merial Inc Dispositivo hiperbarico y metodos para producir vacunas inactivadas y para replegar/solubilizar proteinas recombinates.
WO2016210097A1 (en) * 2015-06-23 2016-12-29 The Trustees Of Columbia University In The City Of New York Novel equine parvovirus and uses thereof
BR112018076015A8 (pt) 2016-06-17 2022-06-28 Sanofi Pasteur Formulações imunogênicas compreendendo adjuvantes de polímero do ácido poliacrílico linear ou ramificado .
JP2023532878A (ja) * 2020-07-07 2023-08-01 アミリス，インコーポレイティド ワクチンアジュバントならびにそれを合成及び使用する方法
CN114272368A (zh) * 2021-12-16 2022-04-05 成都博宠生物科技有限公司 一种猪瘟和猪伪狂犬二联疫苗及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
JPH0832637B2 (ja) * 1985-02-14 1996-03-29 アクゾ・エヌ・ヴエー 合成免疫原
ES2052685T3 (es) * 1987-03-17 1994-07-16 Akzo Nv Metodo para producir un adyuvante libre.
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
EP0532833A1 (en) * 1991-05-28 1993-03-24 Miles Inc. Vaccine for equine rhinopneumonitis
WO1993024528A1 (en) * 1992-06-01 1993-12-09 The University Of Melbourne Equine herpesvirus glycoproteins
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6300118B1 (en) * 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
FR2751226B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
GB9623051D0 (en) * 1996-11-06 1997-01-08 Schacht Etienne H Delivery of DNA to target cells in biological systems
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US6261568B1 (en) * 1997-06-11 2001-07-17 Institut Pasteur Attenuated recombinant mycobacteria useful as immunogens or as vaccine components
US20010007860A1 (en) * 1997-07-14 2001-07-12 Christopher W. Olsen Method of dna vaccination
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
US6444799B1 (en) * 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof

Also Published As

Publication number Publication date
PL343602A1 (en) 2001-08-27
EP1066055A1 (fr) 2001-01-10
DK1066055T3 (da) 2007-06-11
WO1999051269A1 (fr) 1999-10-14
US7163926B1 (en) 2007-01-16
PT1066055E (pt) 2007-05-31
ZA992478B (en) 2000-10-10
AU744964B2 (en) 2002-03-07
CA2327389C (en) 2011-06-14
JP2002510651A (ja) 2002-04-09
DE69935136D1 (de) 2007-03-29
ES2283105T3 (es) 2007-10-16
CA2327389A1 (en) 1999-10-14
AR037062A1 (es) 2004-10-20
BR9909342A (pt) 2000-12-12
EP1066055B1 (fr) 2007-02-14
FR2776928B1 (fr) 2000-06-23
FR2776928A1 (fr) 1999-10-08
AU2844899A (en) 1999-10-25
ATE353670T1 (de) 2007-03-15
PL194348B1 (pl) 2007-05-31
DE69935136T2 (de) 2007-11-29

Similar Documents

Publication Publication Date Title
CY1108013T1 (el) Dna εμβολια για τους ιππους που περιεχουν ανοσοενισχυτικους παραγοντες με πολυμερη του ακρυλικου ή μεθακρυλικου οξεος ή του εμα(r)
BR0209552A (pt) Dispositivo de modulação de imunidade para uso em animais
DK0886644T3 (da) Lang bölgelængde-modificerede fluorescerende proteiner
ATE518956T1 (de) Expressionsvektoren zur stimulierung einer immunantwort und verfahren zu deren verwendung
MX9400837A (es) Metodos y aparatos para la determinacion de secuencia de adn.
ATE334216T1 (de) Impstoff gegen felines immunodefizienz-virus
DE69734882D1 (de) Dna immunisierung gegen chlamydia infektion
ATE335831T1 (de) Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
HRP20070012A2 (en) Immunostimulatory oligonucleotide multimers
FR2741806B1 (fr) Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
NO990025D0 (no) Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA
CY1105439T1 (el) Κυτταρα, μεθοδοι καλλιεργειας και η χρηση τους στη θepαπεια με αυτολογη μεταμοσχευση
BR0114199A (pt) Sequências de nucleotìdeos que medeiam a fertilidade masculina e métodos de uso das mesmas
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
CY1116774T1 (el) Συνθεση η οποια περιεχει lip2a leishmania
DK1227837T3 (da) Fremgangsmåde til introduktion og/eller fremskyndelse af et immunrespons på et tumorantigen
DE69737231D1 (de) Impfung mit nukleinsäuren gegen parvovirus infektionen
DE60139544D1 (de) Veränderte, fluoreszierende proteine
DE60114804D1 (de) Konstruierte fluoreszenzproteine mit langen wellenlängen
DE69700264D1 (de) Homopolymerisation von Polyorganosiloxanen mit Acrylat- oder Methacrylatendgruppe
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
CY1107845T1 (el) Γενετικα εμβολια με ανοσοενισχυτικο
BR9710849A (pt) Vacina contendo uma peróxi-redoxina e/ou uma beta-tubulina.
DE69734586D1 (de) Retinoid-metabolisierendes protein
AR017190A1 (es) Metodo para mejorar la resistencia o tolerancia a patogenos en una planta que comprende integrar en el genoma de dicha planta un gen que codificauna proteina de fusion que comprende una primer y segunda proteina o dominio de proteina con actividad antipatogenica, molecula de adn, su uso, proteinade